英文名稱 |
中文名稱 |
CAS號(hào) |
操作 |
AlbendazoleEPImpurityA |
阿苯達(dá)唑雜質(zhì) |
80983-36-4 |
詳細(xì)
|
ClotrimazoleEPImpurityA |
(2-氯苯基)二苯基甲醇 |
66774-02-5 |
詳細(xì)
|
DiltiazemEPImpurityDHCl |
鹽酸地爾硫卓雜質(zhì)D |
130606-60-9 |
詳細(xì)
|
DiltiazemEPImpurityG |
地爾硫卓雜質(zhì)2 |
81353-09-5 |
詳細(xì)
|
DiosminEPImpurityD |
6-碘代地奧司明 |
1431536-92-3 |
詳細(xì)
|
DomperidoneEPImpurityB |
多潘立酮EP雜質(zhì)B |
1346598-11-5 |
詳細(xì)
|
DomperidoneEPImpurityC |
多潘立酮 雜質(zhì)C |
118435-03-3 |
詳細(xì)
|
BisoprololEPImpurityC |
比索洛爾EP雜質(zhì)C |
1225195-70-9 |
詳細(xì)
|
BisoprololEPImpurityD |
比索洛爾EP雜質(zhì)D |
1225195-71-0 |
詳細(xì)
|
BisoprololEPImpurityN |
比索洛爾EP雜質(zhì)N |
1346601-75-9 |
詳細(xì)
|
BisoprololEPImpurityG |
比索洛爾雜質(zhì)G |
1215342-36-1 |
詳細(xì)
|
BisoprololEPImpurityK |
比索洛爾雜質(zhì)K |
864544-37-6 |
詳細(xì)
|
BisoprololEPImpurityB |
比索洛爾EP雜質(zhì)B |
1447715-44-7 |
詳細(xì)
|
BendamustineDeschloroethylAcidEthylEster |
1H-苯并咪唑-2-丁酸,5-[(2-氯乙基)氨基]-1-甲基-,乙酯 |
2517968-40-8 |
詳細(xì)
|
BisoprololEPImpurityA |
比索洛爾雜質(zhì)A |
62572-93-4 |
詳細(xì)
|
AlbendazoleEPImpurityL |
阿苯達(dá)唑雜質(zhì)L |
108579-67-5 |
詳細(xì)
|
AllopurinolEPImpurityB |
別嘌醇相關(guān)物質(zhì)B |
22407-20-1 |
詳細(xì)
|
AlbendazoleEPImpurityF |
阿苯達(dá)唑雜質(zhì)F |
80983-45-5 |
詳細(xì)
|
AlbendazoleEPImpurityD |
2-氨基-5-丙磺?;讲⑦溥?/td>
| 80983-34-2 |
詳細(xì)
|
AllopurinolEPImpurityE |
別嘌醇相關(guān)物質(zhì)E |
31055-19-3 |
詳細(xì)
|
BendamustineUSPRCD |
苯達(dá)莫司汀 |
1219709-86-0 |
詳細(xì)
|
BrexpiprazoleAcidImpurity |
Brexpiprazole Impurity 49 |
1700655-67-9 |
詳細(xì)
|
CabozantinibImpurity6 |
卡博替尼雜質(zhì)1 |
748707-58-6 |
詳細(xì)
|
BisoprololCarboxylicAcidImpurity |
比索洛爾羧酸雜質(zhì) |
72570-70-8 |
詳細(xì)
|
CabozantinibImpurity16 |
卡博替尼雜質(zhì)HF |
18721-64-7 |
詳細(xì)
|
BosentanUSPRCB |
波生坦USP相關(guān)物質(zhì)B |
174227-14-6 |
詳細(xì)
|
CabozantinibImpurity15 |
卡博替尼雜質(zhì)HF |
213699-53-7 |
詳細(xì)
|
CiprofloxacinEPImpurityD |
環(huán)丙沙星雜質(zhì)D |
133210-96-5 |
詳細(xì)
|
DiltiazemEPImpurityB |
地爾硫卓雜質(zhì)B |
87447-47-0 |
詳細(xì)
|
DiltiazemEPImpurityA |
地爾硫卓EP雜質(zhì)A |
111188-71-7 |
詳細(xì)
|
CabozantinibImpurity17 |
Cabozantinib Impurity 5 |
104330-60-1 |
詳細(xì)
|
AlbendazoleEPImpurityC |
|
75184-71-3 |
詳細(xì)
|
DuloxetineUSPRCH |
度洛西汀相關(guān)物質(zhì)H |
199191-66-7 |
詳細(xì)
|
KetorolacEPImpurityC |
酮咯酸雜質(zhì)C |
1026936-07-1 |
詳細(xì)
|
KetorolacEPImpurityA |
酮咯酸雜質(zhì)A |
154476-25-2 |
詳細(xì)
|
KetorolacEPImpurityB |
酮咯酸雜質(zhì)B |
113502-52-6 |
詳細(xì)
|
Iso-Gatifloxacin |
加替沙星2-甲基哌嗪化合物 |
1029364-65-5 |
詳細(xì)
|
GlimepirideEPImpurityD |
3-乙基-2,5-二氫-4-甲基-N-[2-[3-[[[[(反式-4-甲基環(huán)己基)氨基]羰基]氨基]磺?;鵠苯基]乙基]-2-氧代-1H-吡咯-1-甲酰胺 |
791104-62-6 |
詳細(xì)
|
GlibenclamideEPImpurityB |
格列本脲(優(yōu)降糖)雜質(zhì)B |
21165-77-5 |
詳細(xì)
|
Mesalazine EP Impurity J DiHCl |
美沙拉明EP雜質(zhì)J |
2514682-10-9 |
詳細(xì)
|
EthambutolEPImpurityCDiHCl |
乙胺丁醇相關(guān)物質(zhì)B |
134566-79-3 |
詳細(xì)
|
FamciclovirUSPRCB |
泛昔洛韋相關(guān)物質(zhì)B |
104227-88-5 |
詳細(xì)
|
FenofibrateEPImpurityC |
非諾貝特雜質(zhì)C |
217636-47-0 |
詳細(xì)
|
EthambutolEPImpurityBDiHCl |
乙胺丁醇EP雜質(zhì)B DIHCL |
32454-69-6 |
詳細(xì)
|
FenofibrateEPImpurityD |
非諾貝特雜質(zhì)D |
42019-07-8 |
詳細(xì)
|
FenofibrateEPImpurityG |
非諾貝特雜質(zhì)G |
217636-48-1 |
詳細(xì)
|
FenofibrateEPImpurityF |
非諾貝特雜質(zhì)F |
154356-96-4 |
詳細(xì)
|
FenofibrateEPImpurityE |
非諾貝特雜質(zhì)E |
42019-08-9 |
詳細(xì)
|
Loratadine2-HydroxymethylImpurity |
2-羥甲基氯雷他定 |
609806-39-5 |
詳細(xì)
|
Loratadine4-HydroxymethylImpurity |
4-羥甲基氯雷他定 |
609806-40-8 |
詳細(xì)
|
8-Dechloro-10-chloroLoratadine |
8-丁氯-10-氯氯聯(lián)胺 |
1346605-16-0 |
詳細(xì)
|
LoratadineN-Oxide |
氯雷他定N-氧化物 |
165739-62-8 |
詳細(xì)
|
KetorolacEPImpurityF |
酮咯酸雜質(zhì)F |
1391052-68-8 |
詳細(xì)
|
LevofloxacinEPImpurityH |
左氧氟沙星相關(guān)物質(zhì)C |
177472-30-9 |
詳細(xì)
|
LevofloxacinDiamine |
左氧氟沙星二胺 |
1797510-34-9 |
詳細(xì)
|
KetorolacEPImpurityE |
酮咯酸雜質(zhì)E |
167105-80-8 |
詳細(xì)
|
LosartanEPImpurityF |
氯沙坦鉀EP雜質(zhì)F |
1332713-64-0 |
詳細(xì)
|
LosartanEPImpurityI |
氯沙坦三苯甲基醚 |
1006062-28-7 |
詳細(xì)
|
LosartanEPImpurityJ |
氯沙坦雜質(zhì)J |
1006062-27-6 |
詳細(xì)
|
LosartanEPImpurityE |
5-[2-(4'-甲基聯(lián)苯基)]四唑 |
120568-11-8 |
詳細(xì)
|
LosartanEPImpurityB |
氯沙坦雜質(zhì)B |
160514-13-6 |
詳細(xì)
|
LosartanEPImpurityH |
三苯甲基洛沙坦 |
133909-99-6 |
詳細(xì)
|
MeloxicamEPImpurityD |
美洛昔康EP雜質(zhì)D |
1331636-17-9 |
詳細(xì)
|
RoxadustatMethylEster |
羅沙司他N-1 |
1421312-36-8 |
詳細(xì)
|
LevosimendanImpurity9 |
左西孟旦雜質(zhì)17 |
101328-84-1 |
詳細(xì)
|
NateglinideEPImpurityE |
反式-N-[(4-乙基環(huán)己基)羰基]-D-苯丙氨酸 |
105746-45-0 |
詳細(xì)
|
LevosimendanImpurity6 |
左西孟旦雜質(zhì) |
220246-81-1 |
詳細(xì)
|
MeloxicamEPImpurityF |
4-羥基-2-甲基-2H-1,2-苯并噻嗪-3-甲酸異丙酯 1,1-二氧化物 |
118854-48-1 |
詳細(xì)
|
MeloxicamEPImpurityC |
美洛昔康EP雜質(zhì)C |
1262333-25-4 |
詳細(xì)
|
O-MethylMeloxicam |
美洛昔康USP標(biāo)準(zhǔn)里的雜質(zhì)D |
1391051-96-9 |
詳細(xì)
|
RoxadustatImpurity7 |
4-羥基-1-甲基-7-苯氧基異喹啉-3-羧酸 |
1421312-35-7 |
詳細(xì)
|
LidocaineEPImpurityGHCl |
N-(2,6-二甲基苯基)-2-[(1-甲基乙基)氨基]乙酰胺鹽酸鹽 |
35891-87-3 |
詳細(xì)
|
LidocaineEPImpurityIHCl |
2-(二乙氨基)-N-(2,4-二甲基苯基)乙酰胺鹽酸鹽 |
17289-54-2 |
詳細(xì)
|
LidocaineEPImpurityJHCl |
2-(二乙氨基)-N-(2,5-二甲基苯基)乙酰胺鹽酸鹽 |
1012864-23-1 |
詳細(xì)
|
LidocaineEPImpurityFHCl |
2-(二乙氨基)-N-(2,3-二甲基苯基)乙酰胺鹽酸鹽 |
857170-72-0 |
詳細(xì)
|
RoxadustatImpurity10 |
1-氯-4-羥基-7-苯氧基異喹啉-3-羧酸甲酯 |
1421312-33-5 |
詳細(xì)
|
RoxadustatImpurity9 |
4-羥基-6-苯氧基異喹啉-3-羧酸甲酯 |
1509958-11-5 |
詳細(xì)
|
LidocaineEPImpurityDHCl |
去乙基利多卡因 |
7729-94-4 |
詳細(xì)
|
LevetiracetamImpurity11 |
左乙拉西坦中間體雜質(zhì) |
1031436-47-1 |
詳細(xì)
|
RoxadustatImpurity17 |
2-[(甲氧基羰基甲基)(甲苯-4-磺酰)氨基]甲基-4-苯氧基苯甲酸甲酯 |
1455091-06-1 |
詳細(xì)
|
MontelukastImpurity31 |
(E)-3-[2-(7-氯-2-喹啉基)乙烯基]苯甲醛 |
120578-03-2 |
詳細(xì)
|
N-AcetylDesloratadine |
乙酰地氯雷他定 |
117796-52-8 |
詳細(xì)
|
5,6-Dehydro-N-MethylDesloratadine |
地氯雷他定雜質(zhì) |
117811-18-4 |
詳細(xì)
|
DesloratadineN-CarboxylicAcidMethylEster |
去氯雷他定N-羧酸甲酯 |
165740-03-4 |
詳細(xì)
|
DesloratadineImpurity29 |
氯雷他定雜質(zhì)9 |
125743-81-9 |
詳細(xì)
|
LoratadineImpurity12 |
Loratadine Impurity 12 |
31251-40-8 |
詳細(xì)
|
DesloratadineMethanoneImpurityHCl |
(1-甲基-4-哌啶基)[3-[2-(3-氯苯基)乙基]吡啶-2-基]甲酮鹽酸鹽 |
119770-60-4 |
詳細(xì)
|
8-Dechloro-9-chloro-N-methylDesloratadine |
地氯雷他定雜質(zhì)5 |
38092-88-5 |
詳細(xì)
|
LoratadineImpurity27 |
氯雷他定雜質(zhì)1 |
201466-35-5 |
詳細(xì)
|
MontelukastImpurity32 |
(E)-1-(3-(2-(7-氯-2-喹啉基)乙烯基苯基) -2-丙烯-1-醇 |
149968-10-5 |
詳細(xì)
|
(E)-MontelukastEtherImpurity |
孟魯司特鈉EP雜質(zhì)18 |
1040351-42-5 |
詳細(xì)
|
MontelukastImpurity35 |
孟魯司特鈉相關(guān)雜質(zhì)6 |
1187586-63-5 |
詳細(xì)
|
MontelukastKSM-IILactoneImpurity |
5-Thiaspiro[2.4]heptan-6-one |
162515-66-4 |
詳細(xì)
|
MontelukastDisulfideDiacidImpurity |
疏基酸二硫化物 |
162515-67-5 |
詳細(xì)
|
OseltamivirImpurity28/Ethyl(3R,4R,5S)-4-acetamido-5-(2-formyl-5-(hydroxymethyl)-1H-pyrrol-1-yl)-3-(pentan-3-yloxy)cyclohex-1-ene-1-carboxylate |
奧司他韋雜質(zhì)60 |
2413185-87-0 |
詳細(xì)
|
OseltamivirImpurity29/1,3-Dimethyl-5,5-diallylhexahydropyrimidine-2,4,6-trione/5,5-Diallyl-1,3-dimethylpyrimidine-2,4,6(1H,3H,5H)-trione |
1,3-Dimethyl-5,5-diallylhexahydropyrimidine-2,4,6-trione |
722-97-4 |
詳細(xì)
|
OseltamivirImpurity31/Ethyl(3R,4S,5R)-4,5-dihydroxy-3-(pentan-3-yloxy)cyclohex-1-ene-1-carboxylate |
(3R,4S,5R)-4,5-二羥基-3-(戊烷-3-羥基)環(huán)己-1-烯-1-羧酸乙酯 |
2097777-49-4 |
詳細(xì)
|
OseltamivirImpurity32/(3R,4R,5R)-3,4-Dihydroxy-5-[(methylsulfonyl)oxy]-1-cyclohexene-1-carboxylicacidethylester |
(3R,4R,5R)-3,4-Dihydroxy-5-[(Methylsulfonyl)oxy]-1-cyclohexene-1-carboxylic Acid Ethyl Ester |
220626-12-0 |
詳細(xì)
|
OseltamivirImpurity33/(1S,5R,6R)-5-Hydroxy-7-oxabicyclo[4.1.0]hept-3-ene-3-carboxylicacidethylester |
(1S,5R,6R)-5-Hydroxy-7-oxabicyclo[4.1.0]hept-3-ene-3-carboxylic Acid Ethyl Ester |
876014-27-6 |
詳細(xì)
|
OseltamivirImpurity35/Ethyl(3aR,7R,7aS)-2,2-diethyl-7-hydroxy-3a,6,7,7a-tetrahydrobenzo[d][1,3]dioxole-5-carboxylate |
奧司他韋雜質(zhì)87 |
943515-58-0 |
詳細(xì)
|